Home  |  Contact

Cellosaurus A-431 (CVCL_0037)

[Text version]

Cell line name A-431
Synonyms A431; A431/P
Accession CVCL_0037
Resource Identification Initiative To cite this cell line use: A-431 (RRID:CVCL_0037)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
Doubling time: ~80-100 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Cell surface proteome.
Omics: Deep antibody staining analysis.
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Derived from sampling site: Skin; epidermis.
Sequence variations Gene fusion; EGFR-PPARGC1A (PubMed=23637631).
TP53 p.Arg273His (c.818G>A) (ClinVar=VCV000012366) (PubMed=1394225).
HLA typing Source: PubMed=25960936
Class I
Genome ancestry Source: PubMed=30894373

Origin% genome
Native American0
East Asian, North7.84
East Asian, South0
South Asian6.03
European, North17.15
European, South65.16
Disease Skin squamous cell carcinoma (NCIt: C4819)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_QX11 (A431 siYAP)CVCL_QX12 (A431 YAP-5SA)CVCL_EQ67 (A431-PR)
CVCL_GY97 (A431/CDDP1)CVCL_GY98 (A431/CDDP2)CVCL_4V41 (A431/TPT)
CVCL_3485 (A431NS)CVCL_WS72 (A431PF)
Sex of cell Female
Age at sampling 85Y
Category Cancer cell line
STR profile Source(s): AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; DepMap; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG

AmelogeninX (ATCC; CCRID; CLS; Cosmic-CLP; DepMap; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
X,Y (AddexBio)
D3S135814 (CLS; DepMap; PubMed=25877200)
14,20 (CCRID)
D5S81811,13 (AddexBio)
12,13 (ATCC; CCRID; CLS; Cosmic-CLP; DepMap; DSMZ; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
D21S1128 (CCRID; DepMap; PubMed=25877200)
28,30 (CLS; PubMed=11416159)
Penta D9,11 (CLS)
11 (DepMap; PubMed=25877200)
Penta E12,13

Run an STR similarity search on this cell line
Web pages https://en.wikipedia.org/wiki/A431_cells

PubMed=4357758; DOI=10.1093/jnci/51.5.1417
Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P.
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.
J. Natl. Cancer Inst. 51:1417-1423(1973)

Todaro G.J., De Larco J.E.
Growth factors produced by sarcoma virus-transformed cells.
Cancer Res. 38:4147-4154(1978)

PubMed=6254071; DOI=10.1073/pnas.77.9.5258
Todaro G.J., Fryling C., De Larco J.E.
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.
Proc. Natl. Acad. Sci. U.S.A. 77:5258-5262(1980)

PubMed=22282976; DOI=10.1093/carcin/1.1.21
Day R.S. III, Ziolkowski C.H.J., Scudiero D.A., Meyer S.A., Mattern M.R.
Human tumor cell strains defective in the repair of alkylation damage.
Carcinogenesis 1:21-32(1980)

PubMed=6954533; DOI=10.1073/pnas.79.7.2194
Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., Wong-Staal F.
Differential expression of the amv gene in human hematopoietic cells.
Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982)

PubMed=6092175; DOI=10.1016/0303-7207(84)90053-4
Gamou S., Kim Y.S., Shimizu N.
Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors.
Mol. Cell. Endocrinol. 37:205-213(1984)

PubMed=6500159; DOI=10.1159/000163283
Gershwin M.E., Lentz D., Owens R.B.
Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.
Exp. Cell Biol. 52:361-370(1984)

Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M.
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
Am. J. Pathol. 119:361-366(1985)

Pekkola-Heino K., Kulmala J., Grenman S.E., Carey T.E., Grenman R.
Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
Cancer Res. 49:4876-4878(1989)

PubMed=2228902; DOI=10.1007/BF02624609
Rikimaru K., Toda H., Tachikawa N., Kamata N., Enomoto S.
Growth of the malignant and nonmalignant human squamous cells in a protein-free defined medium.
In Vitro Cell. Dev. Biol. 26:849-856(1990)

Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., Casey G.
Frequent p53 mutations in head and neck cancer.
Cancer Res. 52:5997-6000(1992)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Rantanen V., Grenman S.E., Kurvinen K., Hietanen S., Raitanen M., Syrjanen S.
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)

PubMed=17178626; DOI=10.1080/09553000600969812
Kurvinen K., Rantanen V., Syrjanen S., Johansson B.
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Int. J. Radiat. Biol. 82:859-867(2006)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=22108792; DOI=10.1038/msb.2011.84
Munoz J., Low T.Y., Kok Y.J., Chin A., Frese C.K., Ding V., Choo A., Heck A.J.R.
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells.
Mol. Syst. Biol. 7:550-550(2011)

PubMed=23637631; DOI=10.1371/journal.pgen.1003464
Giacomini C.P., Sun S., Varma S., Shain A.H., Giacomini M.M., Balagtas J., Sweeney R.T., Lai E., Del Vecchio C.A., Forster A.D., Clarke N., Montgomery K.D., Zhu S., Wong A.J., van de Rijn M., West R.B., Pollack J.R.
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
PLoS Genet. 9:E1003464-E1003464(2013)

PubMed=24804581; DOI=10.1021/cb500116c
Giansanti P., Preisinger C., Huber K.V.M., Gridling M., Superti-Furga G., Bennett K.L., Heck A.J.R.
Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics.
ACS Chem. Biol. 9:1490-1498(2014)

PubMed=25960936; DOI=10.4161/21624011.2014.954893
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:E954893-E954893(2014)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25894527; DOI=10.1371/journal.pone.0121314
Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F., Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R., Schmidt A., Mirkowska P., Hartlova A., Van Eyk J.E., Bourquin J.-P., Aebersold R., Boheler K.R., Zandstra P., Wollscheid B.
A mass spectrometric-derived cell surface protein atlas.
PLoS ONE 10:E0121314-E0121314(2015)

PubMed=26989177; DOI=10.1242/dev.133728
Elbediwy A., Vincent-Mistiaen Z.I., Spencer-Dene B., Stone R.K., Boeing S., Wculek S.K., Cordero J., Tan E.H., Ridgway R., Brunton V.G., Sahai E., Gerhardt H., Behrens A., Malanchi I., Sansom O.J., Thompson B.J.
Integrin signalling regulates YAP and TAZ to control skin homeostasis.
Development 143:1674-1687(2016)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28176443; DOI=10.1002/pmic.201600254
Tiwari R., Sahu I., Soni B.L., Sathe G.J., Datta K.K., Thapa P., Sinha S., Vadivel C.K., Dhaka B., Gowda H., Vaidya M.M.
Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of keratin-8 in skin squamous cell carcinoma derived cell line.
Proteomics 17:1600254.1-1600254.17(2017)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

Cell line collections AddexBio; C0012001/22
ATCC; CRL-1555
ATCC; CRL-7907 - Discontinued
BCRC; 60161
BCRJ; 0032
CLS; 300112/p753_A-431
ECACC; 85090402
JCRB; IFO50411
KCB; KCB 200651YJ
KCLB; 21555
KCLB; 80005
NCBI_Iran; C204
RCB; RCB0202
RCB; RCB1872
TKG; TKG 0182
Cell line databases/resources CLDB; cl155
CLDB; cl156
CLDB; cl157
CLDB; cl159
CLDB; cl160
CLDB; cl161
CCRID; 3111C0001CCC000092
CCRID; 3131C0001000700079
CCRID; 3131C0001000700188
CCRID; 3142C0001000000103
Cell_Model_Passport; SIDM00995
Cosmic-CLP; 910925
DepMap; ACH-001328
Lonza; 814
TOKU-E; 476
Ontologies BTO; BTO:0000017
CLO; CLO_0001591
CLO; CLO_0001592
CLO; CLO_0050011
CLO; CLO_0050012
EFO; EFO_0006268
MCCL; MCC:0000025
Biological sample resources BioSample; SAMN01821614
BioSample; SAMN01821671
BioSample; SAMN01821724
BioSample; SAMN03472220
Chemistry resources ChEMBL-Cells; CHEMBL3307523
ChEMBL-Targets; CHEMBL614069
GDSC; 910925
PharmacoDB; A431_46_2019
Gene expression databases ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-2706
ArrayExpress; E-MTAB-3610
GEO; GSM183432
GEO; GSM183433
GEO; GSM827302
GEO; GSM1374384
GEO; GSM1669586
GEO; GSM2112551
GEO; GSM2112555
Other Wikidata; Q4649310
Polymorphism and mutation databases Cosmic; 688038
Cosmic; 735609
Cosmic; 755305
Cosmic; 876559
Cosmic; 897743
Cosmic; 910564
Cosmic; 910925
Cosmic; 974317
Cosmic; 1071898
Cosmic; 1176624
Cosmic; 1351516
Cosmic; 1477434
Cosmic; 1945879
Cosmic; 1995334
Cosmic; 2131571
Cosmic; 2301592
Cosmic; 2646654
IARC_TP53; 21167
IARC_TP53; 23618
Progenetix; CVCL_0037
Proteomic databases PRIDE; PXD000065
PRIDE; PXD000589
PRIDE; PXD000681
PRIDE; PXD001582
PRIDE; PXD003937
PRIDE; PXD006291
PRIDE; PXD005301
PRIDE; PXD007206
PRIDE; PXD008996
Entry history
Entry creation04-Apr-2012
Last entry update12-Jan-2021
Version number37